Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment
PR Newswire•05/08/2026•09:17 ET
0
Whiz Insights
Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment
New institutional accounts ordering LYMPHIR increased 78% quarter over quarter
Get started
Create a free account to read the full story.